Acepromazine
The risk or severity of hypotension can be increased when Acepromazine is combined with Amrinone.
Alfuzosin
The risk or severity of hypotension can be increased when Alfuzosin is combined with Amrinone.
Amitriptyline
The risk or severity of hypotension can be increased when Amitriptyline is combined with Amrinone.
Advertisement
Amobarbital
The metabolism of Amrinone can be increased when combined with Amobarbital.
Amorolfine
The therapeutic efficacy of Amorolfine can be increased when used in combination with Amrinone.
Amoxapine
The risk or severity of hypotension can be increased when Amoxapine is combined with Amrinone.
Advertisement
Amphotericin B
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Amrinone.
amphotericin B liposomal
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Amrinone.
Anidulafungin
The therapeutic efficacy of Anidulafungin can be increased when used in combination with Amrinone.
Advertisement
Aripiprazole
The risk or severity of hypotension can be increased when Aripiprazole is combined with Amrinone.
Artemether
The therapeutic efficacy of Artemether can be increased when used in combination with Amrinone.
Asenapine
The risk or severity of hypotension can be increased when Asenapine is combined with Amrinone.
Barbexaclone
The metabolism of Amrinone can be increased when combined with Barbexaclone.
Barbital
The metabolism of Amrinone can be increased when combined with Barbital.
Benzoic Acid
The therapeutic efficacy of Benzoic Acid can be increased when used in combination with Amrinone.
Bifonazole
The therapeutic efficacy of Bifonazole can be increased when used in combination with Amrinone.
Brexpiprazole
The risk or severity of hypotension can be increased when Brexpiprazole is combined with Amrinone.
Bunazosin
The risk or severity of hypotension can be increased when Bunazosin is combined with Amrinone.
Butenafine
The therapeutic efficacy of Butenafine can be increased when used in combination with Amrinone.
Butoconazole
The therapeutic efficacy of Butoconazole can be increased when used in combination with Amrinone.
Calcium Acetate
The therapeutic efficacy of Amrinone can be decreased when used in combination with Calcium Acetate.
Calcium Carbonate
The therapeutic efficacy of Amrinone can be decreased when used in combination with Calcium Carbonate.
CALCIUM CARBONATE, PRECIPITATED
The therapeutic efficacy of Amrinone can be decreased when used in combination with Calcium Carbonate.
Calcium Chloride
The therapeutic efficacy of Amrinone can be decreased when used in combination with Calcium Chloride.
Calcium Chloride Anhydrous
The therapeutic efficacy of Amrinone can be decreased when used in combination with Calcium Chloride.
Calcium Citrate
The therapeutic efficacy of Amrinone can be decreased when used in combination with Calcium Citrate.
Calcium Glubionate
The therapeutic efficacy of Amrinone can be decreased when used in combination with Calcium glubionate.
Calcium gluceptate
The therapeutic efficacy of Amrinone can be decreased when used in combination with Calcium Gluceptate.
Calcium Gluconate
The therapeutic efficacy of Amrinone can be decreased when used in combination with Calcium gluconate.
Calcium Lactate
The therapeutic efficacy of Amrinone can be decreased when used in combination with Calcium lactate.
CALCIUM LEVULINATE
The therapeutic efficacy of Amrinone can be decreased when used in combination with Calcium levulinate.
Carvedilol
The risk or severity of hypotension can be increased when Carvedilol is combined with Amrinone.
Casein Allergenic Extract
The therapeutic efficacy of Amrinone can be decreased when used in combination with Casein.
Caspofungin
The therapeutic efficacy of Caspofungin can be increased when used in combination with Amrinone.
Chloroxine
The therapeutic efficacy of Chloroxine can be increased when used in combination with Amrinone.
Chlorpromazine
The risk or severity of hypotension can be increased when Chlorpromazine is combined with Amrinone.
Ciclopirox
The therapeutic efficacy of Ciclopirox can be increased when used in combination with Amrinone.
Cimetidine
The serum concentration of Amrinone can be increased when it is combined with Cimetidine.
Clopidogrel
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Amrinone.
Clotrimazole
The therapeutic efficacy of Clotrimazole can be increased when used in combination with Amrinone.
Clozapine
The risk or severity of hypotension can be increased when Clozapine is combined with Amrinone.
Cordycepin
The therapeutic efficacy of Cordycepin can be increased when used in combination with Amrinone.
Cyclosporine
The therapeutic efficacy of Cyclosporine can be increased when used in combination with Amrinone.
Dapiprazole
The risk or severity of hypotension can be increased when Dapiprazole is combined with Amrinone.
Decanoic Acid
The therapeutic efficacy of Capric acid can be increased when used in combination with Amrinone.
Dextroamphetamine
The risk or severity of hypotension can be increased when Dextroamphetamine is combined with Amrinone.
Doxazosin
The risk or severity of hypotension can be increased when Doxazosin is combined with Amrinone.
Doxepin
The risk or severity of hypotension can be increased when Doxepin is combined with Amrinone.
Dronedarone
The risk or severity of hypotension can be increased when Dronedarone is combined with Amrinone.
Droperidol
The risk or severity of hypotension can be increased when Droperidol is combined with Amrinone.
Econazole
The therapeutic efficacy of Econazole can be increased when used in combination with Amrinone.
Econazole Nitrate
The therapeutic efficacy of Econazole can be increased when used in combination with Amrinone.
Efavirenz
The serum concentration of Amrinone can be decreased when it is combined with Efavirenz.
Efinaconazole
The therapeutic efficacy of Efinaconazole can be increased when used in combination with Amrinone.
Epinephrine
The risk or severity of hypotension can be increased when Epinephrine is combined with Amrinone.
Escitalopram
The risk or severity of hypotension can be increased when Escitalopram is combined with Amrinone.
Fluconazole
The therapeutic efficacy of Fluconazole can be increased when used in combination with Amrinone.
Flucytosine
The therapeutic efficacy of Flucytosine can be increased when used in combination with Amrinone.
Flupenthixol
The risk or severity of hypotension can be increased when Flupentixol is combined with Amrinone.
Glyphosate
The therapeutic efficacy of Glyphosate can be increased when used in combination with Amrinone.
Griseofulvin
The therapeutic efficacy of Griseofulvin can be increased when used in combination with Amrinone.
Griseofulvin microsize
The therapeutic efficacy of Griseofulvin can be increased when used in combination with Amrinone.
Haloprogin
The therapeutic efficacy of Haloprogin can be increased when used in combination with Amrinone.
Hexetidine
The therapeutic efficacy of Hexetidine can be increased when used in combination with Amrinone.
Hexobarbital
The metabolism of Amrinone can be increased when combined with Hexobarbital.
Iloperidone
The risk or severity of hypotension can be increased when Iloperidone is combined with Amrinone.
Imipramine
The risk or severity of hypotension can be increased when Imipramine is combined with Amrinone.
Indoramin
The risk or severity of hypotension can be increased when Indoramin is combined with Amrinone.
Isoconazole
The therapeutic efficacy of Isoconazole can be increased when used in combination with Amrinone.
Itraconazole
The therapeutic efficacy of Itraconazole can be increased when used in combination with Amrinone.
Ketoconazole
The therapeutic efficacy of Ketoconazole can be increased when used in combination with Amrinone.
Labetalol
The risk or severity of hypotension can be increased when Labetalol is combined with Amrinone.
Lisdexamfetamine
The risk or severity of hypotension can be increased when Lisdexamfetamine is combined with Amrinone.
Lisdexamfetamine Dimesylate
The risk or severity of hypotension can be increased when Lisdexamfetamine is combined with Amrinone.
Magnesium Hydroxide
The risk or severity of hypotension and neuromuscular blockade can be increased when Amrinone is combined with Magnesium hydroxide.
Magnesium Oxide
The risk or severity of hypotension and neuromuscular blockade can be increased when Amrinone is combined with Magnesium oxide.
Magnesium Salicylate
The risk or severity of hypotension and neuromuscular blockade can be increased when Amrinone is combined with Magnesium salicylate.
Magnesium Sulfate
The risk or severity of hypotension and neuromuscular blockade can be increased when Amrinone is combined with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The risk or severity of hypotension and neuromuscular blockade can be increased when Amrinone is combined with Magnesium sulfate.
Mephobarbital
The metabolism of Amrinone can be increased when combined with Methylphenobarbital.
Methohexital
The metabolism of Amrinone can be increased when combined with Methohexital.
Methotrimeprazine
The risk or severity of hypotension can be increased when Methotrimeprazine is combined with Amrinone.
Micafungin
The therapeutic efficacy of Micafungin can be increased when used in combination with Amrinone.
Miconazole
The therapeutic efficacy of Miconazole can be increased when used in combination with Amrinone.
Miltefosine
The therapeutic efficacy of Miltefosine can be increased when used in combination with Amrinone.
Nafcillin
The therapeutic efficacy of Amrinone can be decreased when used in combination with Nafcillin.
Naftifine
The therapeutic efficacy of Naftifine can be increased when used in combination with Amrinone.
Natamycin
The therapeutic efficacy of Natamycin can be increased when used in combination with Amrinone.
Nefazodone
The risk or severity of hypotension can be increased when Nefazodone is combined with Amrinone.
Nicardipine
The risk or severity of hypotension can be increased when Nicardipine is combined with Amrinone.
Nicergoline
The risk or severity of hypotension can be increased when Nicergoline is combined with Amrinone.
Nitroprusside
Amrinone may increase the hypotensive activities of Nitroprusside.
Nitroxoline
The therapeutic efficacy of Nitroxoline can be increased when used in combination with Amrinone.
Nortriptyline
The risk or severity of hypotension can be increased when Nortriptyline is combined with Amrinone.
Nystatin
The therapeutic efficacy of Nystatin can be increased when used in combination with Amrinone.
Olanzapine
The risk or severity of hypotension can be increased when Olanzapine is combined with Amrinone.
Oxiconazole
The therapeutic efficacy of Oxiconazole can be increased when used in combination with Amrinone.
Pafuramidine
The therapeutic efficacy of Pafuramidine can be increased when used in combination with Amrinone.
Paliperidone
The risk or severity of hypotension can be increased when Paliperidone is combined with Amrinone.
Pentamidine
The therapeutic efficacy of Pentamidine can be increased when used in combination with Amrinone.
Pentobarbital
The metabolism of Amrinone can be increased when combined with Pentobarbital.
Periciazine
The risk or severity of hypotension can be increased when Propericiazine is combined with Amrinone.
Phenobarbital
The metabolism of Amrinone can be increased when combined with Phenobarbital.
Phenoxybenzamine
The risk or severity of hypotension can be increased when Phenoxybenzamine is combined with Amrinone.
Phentolamine
The risk or severity of hypotension can be increased when Phentolamine is combined with Amrinone.
Phentolamine Mesylate
The risk or severity of hypotension can be increased when Phentolamine is combined with Amrinone.
Pizotyline
The risk or severity of hypotension can be increased when Pizotifen is combined with Amrinone.
Posaconazole
The therapeutic efficacy of Posaconazole can be increased when used in combination with Amrinone.
Prazosin
The risk or severity of hypotension can be increased when Prazosin is combined with Amrinone.
Primidone
The metabolism of Amrinone can be increased when combined with Primidone.
Promazine
The risk or severity of hypotension can be increased when Promazine is combined with Amrinone.
Propiomazine
The risk or severity of hypotension can be increased when Propiomazine is combined with Amrinone.
Propiverine
The risk or severity of hypotension can be increased when Propiverine is combined with Amrinone.
Quetiapine
The risk or severity of hypotension can be increased when Quetiapine is combined with Amrinone.
Quetiapine fumarate
The risk or severity of hypotension can be increased when Quetiapine is combined with Amrinone.
Quinidine
The risk or severity of hypotension can be increased when Quinidine is combined with Amrinone.
Racepinephrine
The risk or severity of hypotension can be increased when Racepinephrine is combined with Amrinone.
Rifabutin
The risk or severity of hypotension can be increased when Rifabutin is combined with Amrinone.
Rifampin
The risk or severity of hypotension can be increased when Rifampicin is combined with Amrinone.
Rifapentine
The risk or severity of hypotension can be increased when Rifapentine is combined with Amrinone.
Rifaximin
The risk or severity of hypotension can be increased when Rifaximin is combined with Amrinone.
Risperidone
The risk or severity of hypotension can be increased when Risperidone is combined with Amrinone.
Salicylic Acid
The therapeutic efficacy of Salicylic acid can be increased when used in combination with Amrinone.
Secobarbital
The metabolism of Amrinone can be increased when combined with Secobarbital.
Sertaconazole
The therapeutic efficacy of Sertaconazole can be increased when used in combination with Amrinone.
Silodosin
The risk or severity of hypotension can be increased when Silodosin is combined with Amrinone.
Sirolimus
The therapeutic efficacy of Sirolimus can be increased when used in combination with Amrinone.
Sulconazole
The therapeutic efficacy of Sulconazole can be increased when used in combination with Amrinone.
Tamsulosin
The risk or severity of hypotension can be increased when Tamsulosin is combined with Amrinone.
Tavaborole
The therapeutic efficacy of Tavaborole can be increased when used in combination with Amrinone.
Terazosin
The risk or severity of hypotension can be increased when Terazosin is combined with Amrinone.
Terbinafine
The therapeutic efficacy of Terbinafine can be increased when used in combination with Amrinone.
Terconazole
The therapeutic efficacy of Terconazole can be increased when used in combination with Amrinone.
Thiamylal
The metabolism of Amrinone can be increased when combined with Thiamylal.
Thiopental
The metabolism of Amrinone can be increased when combined with Thiopental.
Thiopental Sodium
The metabolism of Amrinone can be increased when combined with Thiopental.
Thioproperazine
The risk or severity of hypotension can be increased when Thioproperazine is combined with Amrinone.
Thioridazine
The risk or severity of hypotension can be increased when Thioridazine is combined with Amrinone.
Thymol
The therapeutic efficacy of Thymol can be increased when used in combination with Amrinone.
Tioconazole
The therapeutic efficacy of Tioconazole can be increased when used in combination with Amrinone.
Tolazoline
The risk or severity of hypotension can be increased when Tolazoline is combined with Amrinone.
Tolnaftate
The therapeutic efficacy of Tolnaftate can be increased when used in combination with Amrinone.
Trazodone
The risk or severity of hypotension can be increased when Trazodone is combined with Amrinone.
Tricalcium Phosphate
The therapeutic efficacy of Amrinone can be decreased when used in combination with Calcium Phosphate.
Trifluoperazine
The risk or severity of hypotension can be increased when Trifluoperazine is combined with Amrinone.
Trimetrexate
The therapeutic efficacy of Trimetrexate can be increased when used in combination with Amrinone.
Trimipramine
The risk or severity of hypotension can be increased when Trimipramine is combined with Amrinone.
Urapidil
The risk or severity of hypotension can be increased when Urapidil is combined with Amrinone.
Verapamil
The risk or severity of hypotension can be increased when Verapamil is combined with Amrinone.
Voriconazole
The therapeutic efficacy of Voriconazole can be increased when used in combination with Amrinone.
Ziprasidone
The risk or severity of hypotension can be increased when Ziprasidone is combined with Amrinone.
Zuclopenthixol
The risk or severity of hypotension can be increased when Zuclopenthixol is combined with Amrinone.
